Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 1/20 | 0.57 |
| ▸ | TSHR | P16473 | 4/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | GLO1 | Q04760 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | MGAM | O43451 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | SI | P14410 | 1/20 | 0.44 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.44 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methacrylic Acid SCHEMBL9472725 | 1.00 | THRB (0.57) | THRBTSHRALDH1A1LMNAHSD17B10 | |
| Methacrylic Acid SCHEMBL2802555 | 1.00 | THRB (0.57) | THRBTSHRALDH1A1LMNAHSD17B10 | |
| Methacrylic Acid SCHEMBL28847790 | 0.98 | THRB (0.55) | THRBTSHRALDH1A1LMNAHSD17B10 | |
| Methacrylic Acid SCHEMBL29065401 | 0.98 | THRB (0.55) | THRBTSHRALDH1A1LMNAHSD17B10 | |
| Methacrylic Acid SCHEMBL29114833 | 0.98 | THRB (0.55) | THRBTSHRALDH1A1LMNAHSD17B10 | |
| Methacrylic Acid SCHEMBL25171144 | 0.96 | THRB (0.53) | THRBTSHRALDH1A1LMNAHSD17B10 | |
| Methacrylic Acid SCHEMBL17164482 | 0.96 | THRB (0.53) | THRBTSHRALDH1A1LMNAHSD17B10 | |
| Oxalic Acid SCHEMBL7517411 | 0.95 | THRB (0.57) | THRBTSHRALDH1A1LMNAHSD17B10 | |
| Methacrylic Acid SCHEMBL17360628 | 0.94 | THRB (0.52) | THRBTSHRALDH1A1LMNAHSD17B10 | |
| Methacrylic Acid SCHEMBL22164150 | 0.94 | THRB (0.52) | THRBTSHRALDH1A1LMNAHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 452 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4676438-A1 | FILM DELIVERY SYSTEM WITH PERFORATIONS | LTS Lohmann Therapie-Systeme AG (DE) | 2026-01-14 | — | — | EP | claimed |
| WO-2024218397-A1 | PHAGE COMPOSITION | Université Libre de Bruxelles (BE) | 2024-10-24 | — | — | WO | claimed |
| EP-4450066-A1 | PHAGE COMPOSITION | Université Libre de Bruxelles (BE) | 2024-10-23 | — | — | EP | claimed |
| WO-2024184460-A1 | FILM DELIVERY SYSTEM WITH PERFORATIONS | LTS LOHMANN THERAPIE-SYSTEME AG (DE) | 2024-09-12 | — | — | WO | claimed |
| CN-118291037-A | Water-based super-hydrophobic coating and preparation method and application thereof | 中国石油大学(华东) | 2024-07-05 | — | — | CN | claimed |
| US-20240216299-A1 | TRANSMUCOSAL THERAPEUTIC SYSTEM CONTAINING AGOMELATINE | LTS LOHMANN THERAPIE-SYSTEME AG (DE) | 2024-07-04 | — | — | US | claimed |
| CN-118019524-A | Dydrogesterone sustained release pharmaceutical composition | 曼肯制药有限公司 | 2024-05-10 | — | — | CN | claimed |
| WO-2024079518-A1 | MODIFIED RELEASE FORMULATION COMPRISING CAPSAICINOIDS AND A PROCESS | NUTRIVENTIA LIMITED (IN) | 2024-04-18 | — | — | WO | claimed |
| CN-117624953-A | Coating for denitrification film, super-hydrophobic film containing coating and preparation method of super-hydrophobic film | 中国海诚工程科技股份有限公司 | 2024-03-01 | — | — | CN | claimed |
| CN-117503982-A | Gel dressing and preparation method and application thereof | 中国科学院长春应用化学研究所 | 2024-02-06 | — | — | CN | claimed |
| WO-2006008524-A1 | HOLOGRAPHIC SENSOR HAVING HETEROGENEOUS PROPERTIES | CAMBRIDGE ENTERPRISE LIMITED (GB) | 2006-01-26 | — | — | WO | claimed |
| WO-2005044240-A2 | STABLE LANSOPRAZOLE FORMULATION | DEXCEL, LTD. (IL) | 2005-05-19 | — | — | WO | claimed |
| EP-1187599-A4 | STABLE BENZIMIDAZOLE FORMULATION | DEXCEL LTD (IL) | 2004-05-19 | — | — | EP | claimed |
| EP-1187599-A1 | STABLE BENZIMIDAZOLE FORMULATION | Dexcel Ltd. (IL) | 2002-03-20 | — | — | EP | claimed |
| WO-2001040370-A2 | IONICALLY CROSSLINKED HYDROGELS WITH ADJUSTABLE GELATION TIME | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2001-06-07 | — | — | WO | claimed |
| CN-1278733-A | Viscous compositions containing carbon dioxide | MEDICAL RES LAB INC (JP) | 2001-01-03 | — | — | CN | claimed |
| WO-2000078284-A1 | STABLE BENZIMIDAZOLE FORMULATION | DEXCEL LTD. (IL) | 2000-12-28 | — | — | WO | claimed |
| WO-2000055253-A1 | IONOMER COMPOSITE COMPOSITIONS | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2000-09-21 | — | — | WO | claimed |
| CN-1235824-A | Process for producing enteric coated pancreatin granules | IL YANG PHARM CO LTD (KR) | 1999-11-24 | — | — | CN | claimed |
| US-4782100-A | DENTURE LININGS | TOKUYAMA SODA KABUSHIKI KAISHA (JP) | 1988-11-01 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240216299-A1 | TRANSMUCOSAL THERAPEUTIC SYSTEM CONTAINING AGOMELATINE | COMT, SLC6A3, SLC18A2 | THRB 2087/4885TSHR 2150/4885ALDH1A1 996/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.